MEGF10

Chr 5

multiple EGF like domains 10

Also known as: CMYO10A, CMYO10B, CMYP10A, CMYP10B, EMARDD, SR-F3

This gene encodes a member of the multiple epidermal growth factor-like domains protein family. The encoded protein plays a role in cell adhesion, motility and proliferation, and is a critical mediator of apoptotic cell phagocytosis as well as amyloid-beta peptide uptake in the brain. Expression of this gene may be associated with schizophrenia, and mutations in this gene are a cause of early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD) as well as congenital myopathy with minicores. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.35
Clinical SummaryMEGF10
🧬
Gene-Disease Validity (ClinGen)
MEGF10-related myopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.23) despite low pLI — interpret in context.
📋
ClinVar Variants
62 unique Pathogenic / Likely Pathogenic· 579 VUS of 1162 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.35LOEUF
pLI 0.390
Z-score 5.85
OE 0.23 (0.150.35)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.05Z-score
OE missense 0.89 (0.830.95)
608 obs / 685.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.23 (0.150.35)
00.351.4
Missense OE?0.89 (0.830.95)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 15 / 66.5Missense obs/exp: 608 / 685.3Syn Z: 0.76
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMEGF10-related myopathy, early-onset, areflexia, respiratory distress, and dysphagiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6258th %ile
GOF
0.6541th %ile
LOF
0.4430th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

1162 submitted variants in ClinVar

Classification Summary

Pathogenic32
Likely Pathogenic30
VUS579
Likely Benign398
Benign53
Conflicting65
32
Pathogenic
30
Likely Pathogenic
579
VUS
398
Likely Benign
53
Benign
65
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
29
3
0
0
32
Likely Pathogenic
26
3
1
0
30
VUS
4
470
100
5
579
Likely Benign
0
4
206
188
398
Benign
0
2
46
5
53
Conflicting
65
Total594823531981,157

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

18 pathogenic / likely-pathogenic (of 25) ClinVar copy-number / structural variants overlap MEGF10 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MEGF10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →